StronBone and StronBone-P - Formulation Optimisation Scale Up Pre-clinical Testing Clinical Trial Design and Planning

Lead Participant: REPREGEN LIMITED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Lead Participant

Project Cost

Grant Offer

REPREGEN LIMITED £211,040 £ 102,679
 

Participant

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE £86,600 £ 86,600
UNIVERSITY COLLEGE LONDON £134,804 £ 134,804

People

ORCID iD

Publications

10 25 50